Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Signore

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Nature Immunology|September 17, 2024
Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology|August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Nature Immunology|September 17, 2024
Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology|August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Pageof 7